Cite

HARVARD Citation

    Aggarwal, R. et al. (2014). Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis1. Arthritis & rheumatology. 66 (3), pp. 740-749. [Online]. 
  
Back to record